Asenapine Pharmacokinetics in Hepatic and Renal Impairment

By Peeters Pierre  

Clinical Pharmacokinetics, Vol. 50, Iss. 7, 2011-07 ,pp. : 471-481

Adis International

Access to resources Recommend Favorite

Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Saxagliptin

By Boulton David W.   Li Li   Frevert Ernst U.   Tang Angela   Castaneda Lorna   Vachharajani Nimish N.   Kornhauser David M.   Patel Chirag G.  

Clinical Pharmacokinetics, Vol. 50, Iss. 4, 2011-04 ,pp. : 253-265

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Vandetanib in Subjects with Renal or Hepatic Impairment

By Weil Angelika  

Clinical Pharmacokinetics, Vol. 49, Iss. 9, 2010-09 ,pp. : 607-618

Adis International

Access to resources Recommend Favorite

Effects of Renal Impairment and Hepatic Impairment on the Pharmacokinetics of Hydrocodone After Administration of a Hydrocodone Extended‐Release Tablet Formulated With Abuse‐Deterrence Technology

By  

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 2, 2016-03 ,pp. : 141-149

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of hepatic or renal impairment on the pharmacokinetics of casopitant, a NK-1 receptor antagonist

By Bauman John  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 662-671

Springer Publishing Company

Access to resources Recommend Favorite